Wednesday, June 13, 2018

BridgeBio launches CoA Therapeutics to treat a rare neurodegenerative disease

The startup is developing allosteric activators to increase levels of the vital metabolic molecule coenzyme A in pantothenate kinase-associated neurodegeneration

via Chemical & Engineering News: Biological SCENE https://ift.tt/2JSB9x5
Posted by at
Labels: ,

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)